Urinary Tract Infections Market Key Market Players Pfizer, Inc., AstraZeneca plc, Johnson & Johnson, Novartis International AG., F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, and Cipla Ltd., among others.

Market Overview:

In the year 2018 Global Urinary Tract Infections Market was valued at USD 10.07 billion. By the year 2023, it is predicted to reach USD 11.19 billion with pace of 2.14% CAGR.

Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. When the infection is occurred in the lower urinary tract it is called as a bladder infection or cystitis and when it affects the upper urinary tract it is called kidney infection or pyelonephritis. Major symptoms caused due to urinary tract are increased frequent urination, painful urination, excessive and involuntary passing of urine.

Request Report Sample:  https://www.marketdataforecast.com/market-reports/urinary-tract-infections-market-4547/request-sample

Factors affecting market growth:

Increasing geriatric population across the globe. (+)
Rising chronic kidney diseases and diabetes globally. (+)
Technological advancement in testing devices. (+)
Increasing healthcare expenditure. (+)
Introduction of new devices like portable and battery-operated urinary tract infections devices. (+)
Growing demand for urinary tract infections treatment in the developing countries. (+)
Huge investment for research and development activities. (-)
Stringent government regulations. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/urinary-tract-infections-market-4547/customize-report

Market Segmentation

The Global Urinary Tract Infections Market is segmented on the basis of

Type of Medication

Penicillin & Combinations
(Amoxicillin, Amoxicillin-Clavulanate Potassium combination)

Quinolones
(Ciprofloxacin, Levofloxacin, Norfloxacin, and Nalidixic Acid)

Aminoglycoside-Antibodies
(Gentamicin, Amikacin)

Cephalosporin
(Ceftriaxone, Cefixime, Cefuroxime, Cephalexin)

Sulphonamides
(Sulfamethoxazole, Trimethoprim combination)

Azoles & Amphotericin B
Tetracycline
(Doxycycline, Nitrofurans)

Nitrofurans
Type of Indication

Uncomplicated UTI
Complicated UTI
Recurring Complicated UTI
Neurogenic Bladder Infection
Based on type of medication market, Quinolones segment holds the largest market share in the Global Urinary Tract Infections Market due to Ciprofloxacin, and levofloxacin are mostly used drugs for Urinary Tract treatment.

Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/urinary-tract-infections-market-4547/

Key players:

Leading companies for Global Urinary Tract Infections Market are F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., Pfizer, Inc., AstraZeneca plc, Johnson & Johnson, and Novartis International AG.

Market Overview:

In the year 2018 Global Urinary Tract Infections Market was valued at USD 10.07 billion. By the year 2023, it is predicted to reach USD 11.19 billion with pace of 2.14% CAGR.

Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. When the infection is occurred in the lower urinary tract it is called as a bladder infection or cystitis and when it affects the upper urinary tract it is called kidney infection or pyelonephritis. Major symptoms caused due to urinary tract are increased frequent urination, painful urination, excessive and involuntary passing of urine.

Request Report Sample:  https://www.marketdataforecast.com/market-reports/urinary-tract-infections-market-4547/request-sample

Factors affecting market growth:

Increasing geriatric population across the globe. (+)
Rising chronic kidney diseases and diabetes globally. (+)
Technological advancement in testing devices. (+)
Increasing healthcare expenditure. (+)
Introduction of new devices like portable and battery-operated urinary tract infections devices. (+)
Growing demand for urinary tract infections treatment in the developing countries. (+)
Huge investment for research and development activities. (-)
Stringent government regulations. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/urinary-tract-infections-market-4547/customize-report

Market Segmentation

The Global Urinary Tract Infections Market is segmented on the basis of

Type of Medication

Penicillin & Combinations
(Amoxicillin, Amoxicillin-Clavulanate Potassium combination)

Quinolones
(Ciprofloxacin, Levofloxacin, Norfloxacin, and Nalidixic Acid)

Aminoglycoside-Antibodies
(Gentamicin, Amikacin)

Cephalosporin
(Ceftriaxone, Cefixime, Cefuroxime, Cephalexin)

Sulphonamides
(Sulfamethoxazole, Trimethoprim combination)

Azoles & Amphotericin B
Tetracycline
(Doxycycline, Nitrofurans)

Nitrofurans
Type of Indication

Uncomplicated UTI
Complicated UTI
Recurring Complicated UTI
Neurogenic Bladder Infection
Based on type of medication market, Quinolones segment holds the largest market share in the Global Urinary Tract Infections Market due to Ciprofloxacin, and levofloxacin are mostly used drugs for Urinary Tract treatment.

Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/urinary-tract-infections-market-4547/

Key players:

Leading companies for Global Urinary Tract Infections Market are F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., Pfizer, Inc., AstraZeneca plc, Johnson & Johnson, and Novartis International AG.

About Us :
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.

Info:                                                                                               
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film    Nagar, Hyderabad, Telangana 500033, India.

Phone: +1-888-702-9626

This release was published on openPR.